--- title: Buy Daliresp (Roflumilast) 500mg Pills Online description: Daliresp (Roflumilast) 500mg Pills treat severe COPD to reduce exacerbations. Order this trusted maintenance medication from our secure online pharmacy. type: product language: en url: https://liabilis.com/order-daliresp-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 65.54 price_max: 208.99 currency: USD offers: - name: 500mg x 30 pills price: 65.54 - name: 500mg x 60 pills price: 104.49 - name: 500mg x 90 pills price: 141.99 - name: 500mg x 120 pills price: 157.69 - name: 500mg x 180 pills price: 208.99 --- # Buy Daliresp (Roflumilast) 500mg Pills Online Daliresp, containing the active ingredient Roflumilast, is a phosphodiesterase-4 inhibitor developed for managing severe chronic obstructive pulmonary disease (COPD). It helps reduce the frequency of exacerbations in adults with chronic bronchitis and a history of exacerbations. This maintenance treatment is specifically designed for patients seeking to improve lung function and quality of life. Our pharmacy provides Daliresp in 500mg pills from verified sources. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **500mg** | 30 pills | **$65.54** | $2.18 | In Stock | | **500mg** | 60 pills | **$104.49** | $1.74 | In Stock | | **500mg** | 90 pills | **$141.99** | $1.58 | In Stock | | **500mg** | 120 pills | **$157.69** | $1.31 | In Stock | | **500mg** | 180 pills | **$208.99** | $1.16 | In Stock | [Buy Now](https://liabilis.com/order-daliresp-online-en.html) ## Introduction Daliresp is a prescription medication that contains the active ingredient roflumilast. It is supplied as a 500 mg oral pill and belongs to the phosphodiesterase-4 (PDE4) inhibitor class. The drug is primarily indicated for the long-term management of chronic obstructive pulmonary disease (COPD) in adults with a history of exacerbations. Secondary uses have not been formally approved. --- ## Quick Reference Facts **Active Ingredient** : Roflumilast **Form** : Pill 500 mg **Primary Uses** : • Maintenance therapy for COPD with frequent exacerbations --- ## What is Daliresp? Daliresp is the generic version of medications containing the active compound roflumilast. It is marketed under brand names such as Daliresp and may be prescribed when a cost-effective alternative to brand-only options is desired. As a generic, it must demonstrate bioequivalence to the reference brand in terms of absorption, distribution, metabolism, and excretion. The medication is manufactured by several licensed pharmaceutical companies that comply with international Good Manufacturing Practices (GMP). --- ## How Daliresp Works Roflumilast inhibits the enzyme phosphodiesterase-4, which breaks down cyclic adenosine monophosphate (cAMP) within inflammatory cells. By raising intracellular cAMP levels, the drug reduces the release of pro-inflammatory cytokines such as tumor necrosis factor-α, interleukin-8, and leukotrienes. This dampening of inflammation leads to fewer airway narrowing episodes and a lower risk of COPD exacerbations. The onset of anti-inflammatory effect typically appears within several weeks of daily dosing, and steady-state plasma concentrations are reached after approximately 4 weeks. Roflumilast is metabolized mainly by CYP3A4 and CYP1A2 and is eliminated via the kidneys. --- ## Conditions Treated with Daliresp - **Chronic obstructive pulmonary disease (COPD) with a history of exacerbations** Daliresp reduces the frequency of moderate and severe COPD exacerbations by targeting airway inflammation that is not fully controlled by bronchodilators alone. - **COPD patients receiving long-acting bronchodilator therapy** When added to a regimen of long-acting muscarinic antagonists (LAMAs) or long-₂-agonists (LABAs), Daliresp provides additional protection against exacerbations. *(Only approved indications are listed; off-label uses are discussed later.)* --- ## Is Daliresp the Right Medication for You? Daliresp is most suitable for adults with COPD who: - Have experienced two or more moderate exacerbations or at least one severe exacerbation in the previous year despite optimal bronchodilator therapy. - Are already receiving maintenance inhaled therapy (e.g., LABA/LAMA combinations). - Do not have contraindications such as severe hepatic impairment or a history of hypersensitivity to roflumast. Patients who should avoid Daliresp include those with: - Active, uncontrolled infections (e.g., severe pneumonia). - Significant weight loss (>5 % of body weight) or a body mass index (BMI) < 18 kg/m², as weight loss is a known effect. - Moderate to severe liver disease (Child-Pugh B or C). A thorough clinical assessment is required before initiating therapy. --- ## Buying Daliresp from [our online pharmacy](https://liabilis.com/order-daliresp-online-en.html) ### Why Choose Our Service? Accessing Daliresp can be challenging due to insurance restrictions or geographic availability. Our platform offers a reliable route to obtain the medication at a price close to manufacturer cost, helping patients maintain continuity of care without financial strain. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. All suppliers adhere to recognized regulatory frameworks, and each batch of Daliresp is verified against the original labeling specifications before shipment. ### Pricing & Access Because Daliresp is a generic formulation, it is offered at a substantially lower cost than brand-only options. Patients benefit from transparent pricing, with no hidden fees, making long-term therapy more affordable. ### Discreet Delivery Orders are packaged in neutral, tamper-evident envelopes and dispatched via express courier (typically within 7 days) or standard airmail (approximately 3 weeks). Privacy is maintained throughout the shipping process, and tracking information is provided for every shipment. --- ## Use: Dosing, Missed Dose, Overdose - **Standard dosing**: Specific information about Daliresp 500 mg dosing is limited in publicly available sources. Patients should follow the prescribing physician’s instructions. - **Missed dose**: If a dose is forgotten, take it as soon as remembered unless the next scheduled dose is near; in that case, skip the missed dose and resume the regular schedule. Do not double-dose. - **Overdose**: Signs may include severe nausea, vomiting, abdominal pain, or dizziness. Seek emergency medical care immediately; supportive care and gastrointestinal decontamination are the mainstays of treatment. **Practical precautions** - Take the pill with food to lessen gastrointestinal discomfort. - Avoid concurrent use of strong CYP3A4 inhibitors (e.g., ketoconazole) without medical guidance. - Refrain from operating heavy machinery until you know how Daliresp affects you, as dizziness can occur. --- ## Safety Information ### Should Not Take Daliresp - Patients with severe hepatic impairment (Child-Pugh C). - Individuals with a known hypersensitivity to roflumilast or any tablet excipients. - Those currently experiencing active, uncontrolled infections. ### Common Side Effects - **Gastrointestinal**: Diarrhea, nausea, abdominal pain (often mild to moderate). - **Metabolic**: Weight loss, decreased appetite. - **Neurological**: Headache, insomnia, dizziness. These effects usually appear early in therapy and may lessen over time. Maintaining adequate nutrition and hydration can mitigate many symptoms. ### Serious Side Effects (Seek Immediate Medical Help) - **Psychiatric**: Depression, suicidal thoughts, or behavior. - **Severe allergic reactions**: Rash, swelling of face or throat, difficulty breathing. - **Hepatic concerns**: Jaundice, dark urine, elevated liver enzymes. If any of these occur, discontinue Daliresp and contact emergency services. ### Drug & Food Interactions - **CYP3A4 inhibitors** (e.g., itraconazole, clarithromycin) → may increase roflumilast levels; dose adjustment may be required. - **CYP3A4 inducers** (e.g., rifampin, carbamazepine) → may reduce efficacy. - **Warfarin** → roflumilast can modestly increase INR; monitor coagulation parameters. - **Alcohol** → may exacerbate gastrointestinal side effects; moderation is advised. --- ## Off-Label and Investigational Uses of Daliresp - **Severe asthma**: Some clinical studies have explored roflumilast as an adjunct for steroid-resistant asthma, showing modest improvements in lung function. - **Psoriasis**: Topical and oral formulations have been investigated for inflammatory skin disorders, but data remain preliminary. These uses are not approved by regulatory agencies. Off-label use should only be considered under the direct supervision of a qualified healthcare provider, as safety and efficacy have not been definitively established. --- ## Storage & Handling - Store tablets at room temperature between 15 °C and 30 °C (59 °F - 86 °F). - Keep the container tightly closed, away from moisture and direct sunlight. - Do not use the medication after the expiration date printed on the packaging. - Dispose of unused tablets in accordance with local hazardous waste regulations or return them to a pharmacy for safe disposal. --- ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Daliresp?** Yes, but keep the medication in its original packaging with the prescription label visible. Some countries require a doctor's note for chronic respiratory drugs; verify local import rules before departure. - **Should I take Daliresp at a specific time of day?** Consistency improves therapeutic effect. Most clinicians advise taking it in the morning with food to reduce gastrointestinal upset. - **Is it safe to drink coffee while on Daliresp?** Moderate caffeine intake does not significantly interact with roflumilast. Excessive amounts may worsen insomnia, a known side effect. **Product Information** - **What does a Daliresp tablet look like?** The generic tablet is typically white, round, and film-coated, bearing the imprint “500 MG”. Tablet appearance can vary slightly between manufacturers. - **Are there any inactive ingredients I should be aware of?** Common excipients include lactose, microcrystalline cellulose, and magnesium stearate. Patients with lactose intolerance should consult their pharmacist. **Safety & Regulations** - **Will Daliresp show up on a standard drug test?** Roflumilast is not part of typical occupational or sports drug-testing panels and is unlikely to be detected unless a specialized assay is performed. - **Is Daliresp safe for athletes subject to anti-doping rules?** The World Anti-Doping Agency (WADA) does not list roflumilast as a prohibited substance. Nevertheless, athletes should inform their medical team of all medications. - **Can elderly patients use Daliresp?** Older adults may be more susceptible to weight loss and gastrointestinal effects; dose adjustments are not routinely required but close monitoring is advisable. **Scientific & Clinical Curiosity** - **What was the key trial that led to Daliresp’s approval?** The pivotal Phase III trial (CTR-M241) demonstrated a 30 % reduction in COPD exacerbations versus placebo when added to standard bronchodilator therapy. - **How does Daliresp differ from earlier COPD drugs?** Unlike bronchodilators that target airway smooth muscle, roflumilast modulates the inflammatory cascade, providing a complementary mechanism of action. --- ## Glossary **Phosphodiesterase-4 (PDE4) inhibitor** : A of drugs that block the PDE4 enzyme, leading to increased cAMP levels and reduced inflammation in airway cells. **Exacerbation** : A worsening of COPD symptoms that typically requires additional medical treatment, such as oral steroids or antibiotics. **Bioequivalence** : Demonstration that a generic product delivers the same amount of active ingredient to the bloodstream as the reference brand, within an accepted margin. --- ## Disclaimer The information provided about **Daliresp** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-daliresp-online-en.html) offers access to **Daliresp** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.